Modification of cardiac disease by histone deacetylase 6 in pressure-overloaded hypertrophy

被引：0
|
作者：
Sanbe, A. [1 ]
Matsushita, N. [1 ]
Aoyagi, T. [1 ]
Takahashi, N. [1 ]
Tezuka, Y. [1 ]
Nishigori, H. [1 ]
Hirose, M. [1 ]
机构：
[1] Iwate Med Univ, Iwate, Yahabacho, Japan
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5590
引用
收藏
页码：1009 / 1009
页数：1
相关论文
共 50 条
  • [21] Adenylyl Cyclase 6 Deletion Reduces Left Ventricular Hypertrophy, Dilation, Dysfunction, and Fibrosis in Pressure-Overloaded Female Mice
    Tang, Tong
    Lai, N. Chin
    Hammond, H. Kirk
    Roth, David M.
    Yang, Yuan
    Guo, Tracy
    Gao, Mei Hua
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (14) : 1476 - 1486
  • [22] Effect of Zhenwu Tang Granule on pressure-overloaded left ventricular myocardial hypertrophy in rats
    Xie, Zhi-xiang
    Wang, Shu-yin
    Liang, Zi-jing
    Zeng, Liang-bo
    WORLD JOURNAL OF EMERGENCY MEDICINE, 2010, 1 (02) : 149 - 153
  • [23] Dystrophin upregulation in pressure - Overloaded cardiac hypertrophy in rats
    Maeda, M
    Biro, S
    Kamogawa, Y
    Hirakawa, T
    Setoguchi, M
    Tei, C
    CELL MOTILITY AND THE CYTOSKELETON, 2003, 55 (01): : 26 - 35
  • [24] Quantitative Phosphoproteomic Study of Pressure-Overloaded Mouse Heart Reveals Dynamin-Related Protein 1 as a Modulator of Cardiac Hypertrophy
    Chang, Yu-Wang
    Chang, Ya-Ting
    Wang, Qinchuan
    Lin, Jim Jung-Ching
    Chen, Yu-Ju
    Chen, Chien-Chang
    MOLECULAR & CELLULAR PROTEOMICS, 2013, 12 (11) : 3094 - 3107
  • [25] Vildagliptin Attenuates Cardiac Hypertrophy and Improves Ventricular Efficiency Through FGF21 Expression in Pressure-overloaded Mouse Heart
    Furukawa, Nozomi
    Koitabashi, Norimichi
    Sunaga, Hiroaki
    Obokata, Masaru
    Umbarawan, Yogi
    Syamsunarno, Mas R.
    Yamaguchi, Aiko
    Matsui, Hiroki
    Yokoyama, Tomoyuki
    Kurabayashi, Masahiko
    CIRCULATION, 2016, 134
  • [26] Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMT
    Masada, Kenta
    Miyagawa, Shigeru
    Sakai, Yoshiki
    Harada, Akima
    Kanaya, Tomomitsu
    Sawa, Yoshiki
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 19 : 210 - 219
  • [27] Vildagliptin Attenuates Cardiac Hypertrophy and Improves Ventricular Efficiency Through FGF21 Expression in Pressure-overloaded Mouse Heart
    Furukawa, Nozomi
    Koitabashi, Norimichi
    Sunaga, Hiroaki
    Obokata, Masaru
    Umbarawan, Yogi
    Syamsunarno, Mas R.
    Yamaguchi, Aiko
    Matsui, Hiroki
    Yokoyama, Tomoyuki
    Kurabayashi, Masahiko
    CIRCULATION, 2016, 134
  • [28] Changes in Ca2+ cycling proteins underlie cardiac action potential prolongation in a pressure-overloaded guinea pig model with cardiac hypertrophy and failure
    Ahmmed, GU
    Dong, PH
    Song, GJ
    Ball, NA
    Xu, YF
    Walsh, RA
    Chiamvimonvat, N
    CIRCULATION RESEARCH, 2000, 86 (05) : 558 - 570
  • [29] Histone deacetylase 6 in health and disease
    Seidel, Carole
    Schnekenburger, Michael
    Dicato, Mario
    Diederich, Marc
    EPIGENOMICS, 2015, 7 (01) : 103 - 118
  • [30] Blockade of TGF-β prevents cardiac fibrosis and diastolic dysfunction in pressure-overloaded rats
    Kuwahara, F
    Kai, H
    Niiyama, H
    Shibata, R
    Nagata, T
    Seki, Y
    HYPERTENSION, 1999, 34 (02) : 347 - 348
12345